Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lisata Therapeutics (LSTA) Accumulated Depreciation & Amortization (2016 - 2025)

Lisata Therapeutics filings provide 11 years of Accumulated Depreciation & Amortization readings, the most recent being $476000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 19.19% year-over-year to $476000.0, compared with a TTM value of $476000.0 through Dec 2025, down 19.19%, and an annual FY2025 reading of $476000.0, down 19.19% over the prior year.
  • Accumulated Depreciation & Amortization hit $476000.0 in Q4 2025 for Lisata Therapeutics, up from $472000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $615000.0 in Q1 2025, with the low at $189000.0 in Q4 2023.
  • Median Accumulated Depreciation & Amortization over the past 3 years was $495500.0 (2024), compared with a mean of $480416.7.
  • The sharpest move saw Accumulated Depreciation & Amortization soared 211.64% in 2024, then decreased 19.19% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $189000.0 in 2023, then surged by 211.64% to $589000.0 in 2024, then fell by 19.19% to $476000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $476000.0, $472000.0, and $518000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.